Australians with ADHD enduring shortage of critical drug

Millions of Australians with ADHD are facing a shortage of a critical drug, with many forced to reduce their dosage or go without their medication altogether.

The drug, dexamphetamine, is a stimulant that is used to treat ADHD. It is the most commonly prescribed ADHD medication in Australia, with more than 15 million Australians prescribed the drug in the 2020-21 financial year.

However, there has been a global shortage of dexamphetamine in recent months, due to a number of factors, including manufacturing delays and increased demand. This has led to a shortage of the drug in Australia, with many pharmacies running out of stock.

The shortage has had a significant impact on Australians with ADHD. Many have been forced to reduce their dosage of dexamphetamine, which can lead to a worsening of their symptoms. Others have been forced to go without their medication altogether, which can have a devastating impact on their lives.

The Australian ADHD Professionals Association (AADA) has called on the government to take action to address the shortage. The AADA has urged the government to increase the production of dexamphetamine in Australia and to allow the importation of the drug from other countries.

The government has said that it is working to address the shortage, but it is unclear when the situation will improve.

In the meantime, Australians with ADHD are urged to speak to their doctor about their medication options. There are a number of other ADHD medications available, and your doctor can help you find the best option for you.